Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis (Q26991523)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis	scientific article

Statements

scholarly article

1 reference

7 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

19 June 2019

7 November 2019

27 October 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis (English)

1 reference

gestational diabetes

7 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

19 June 2019

7 November 2019

27 October 2020

1 reference

7 November 2019

polycystic ovary syndrome

8 references

based on heuristic

inferred from title

13 March 2019

14 March 2019

24 March 2019

3 April 2019

19 June 2019

7 November 2019

27 October 2020

1 reference

based on heuristic

inferred from title

human pregnancy

1 reference

based on heuristic

inferred from title

anti-diabetic medication

1 reference

27 October 2020

systematic review

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Zhihong Zhuo

1

1 reference

Aiming Wang

2

1 reference

Huimin Yu

3

1 reference

language of work or name

1 reference

publication date

2014

1 reference

21 May 2014

8 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

19 June 2019

7 November 2019

29 May 2020

27 October 2020

Journal of Diabetes Research

8 references

13 March 2019

14 March 2019

24 March 2019

3 April 2019

19 June 2019

7 November 2019

27 October 2020

2014

1 reference

381231

1 reference

copyright license

Creative Commons Attribution 3.0 Unported

7 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

14 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

3 April 2019

Europe PubMed Central

19 June 2019

Europe PubMed Central

7 November 2019

Europe PubMed Central

27 October 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

21 March 2017

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

21 March 2017

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1155/2014/381231

22 April 2017

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Obstetrical care in gestational diabetes and management of preterm labour

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

The management of polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

28 September 2017

Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Nutrition, insulin and polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055053

31 May 2018

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Population pharmacokinetics of metformin in late pregnancy

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Placental passage of metformin in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin for gestational diabetes in routine clinical practice.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F381231

21 January 2018

Metformin treatment in pregnant women with polycystic ovary syndrome--is reduced complication rate mediated by changes in the uteroplacental circulation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24963493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24963493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24963493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24963493

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2014/381231

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26991523&oldid=1590349903"